BioPharma Credit PLC (FRA:B3P)

Germany flag Germany · Delayed Price · Currency is EUR
0.7950
-0.0350 (-4.22%)
At close: Feb 20, 2026
Market Cap891.39M -8.0%
Revenue (ttm)131.70M +13.4%
Net Income104.84M +12.6%
EPS0.09 +22.2%
Shares Outn/a
PE Ratio8.50
Forward PEn/a
Dividend0.07 (8.78%)
Ex-Dividend DateFeb 19, 2026
Volumen/a
Average Volume990
Open0.7950
Previous Close0.8300
Day's Range0.7950 - 0.7950
52-Week Range0.6900 - 0.8950
Betan/a
RSI51.42
Earnings DateMar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom. [Read more]

Industry Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
Founded 2016
Country United Kingdom
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol B3P
Full Company Profile

Financial Performance

In 2024, BioPharma Credit's revenue was $150.03 million, an increase of 10.53% compared to the previous year's $135.74 million. Earnings were $122.18 million, an increase of 12.66%.

Financial numbers in USD Financial Statements